McKesson (MCK) Fundamentals 2026 — P/E 21.3x, Revenue Analysis | SniperIQ
McKesson (MCK) is a US-listed Healthcare company in Medical - Distribution with a market capitalization of $96.3B, trading at $822.11 on the NYSE. This SniperIQ fundamentals page covers McKesson's valuation (P/E 21.3x), profitability (net margin 1.2%), revenue ($403.4B in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is McKesson's market cap?
McKesson (MCK) has a market capitalization of approximately $96.3B, trading at $822.11 on the NYSE. Market cap moves with the live share price.
What is McKesson's P/E ratio?
McKesson's trailing twelve-month P/E ratio is 21.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is McKesson?
McKesson runs a net profit margin of 1.2%, a gross margin of 3.6%, and an operating margin of 1.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does McKesson generate?
McKesson reported revenue of $403.4B for fiscal year 2026, with net income of $4.8B and earnings per share (EPS) of 38.55. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does McKesson pay a dividend?
McKesson offers a trailing dividend yield of about 0.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is McKesson financially healthy?
McKesson carries a debt-to-equity ratio of -3.97x and a current ratio of 0.85x, with a market beta of 0.32. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is McKesson a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For McKesson (MCK) the key facts are: market cap $96.3B, P/E 21.3x, revenue $403.4B, 52-week range 637-999. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track McKesson's full fundamentals live
Get McKesson's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.